Related Experiment Videos
Cardiomyopathy in transgenic myf5 mice
J G Edwards1, G E Lyons, B K Micales
1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Circulation Research
|March 1, 1996
Summary
Introducing a skeletal muscle gene into the heart of transgenic mice caused severe cardiomyopathy and reduced lifespan. This highlights the incompatibility of skeletal and cardiac muscle proteins, leading to heart failure.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Developmental Biology
Background:
- Skeletal and cardiac muscle share some regulatory pathways but have distinct functional and structural proteins.
- Understanding the compatibility of these muscle programs is crucial for cardiac health.
Purpose of the Study:
- To investigate the consequences of expressing a skeletal muscle regulator (bmyf5) in the heart.
- To determine if skeletal muscle gene expression is compatible with cardiac function.
Main Methods:
- Generation of transgenic mice expressing bmyf5 in the heart.
- Analysis of cardiac pathology, gene expression, and lifespan.
- Biochemical assays of myofibrillar ATPase activity.
Main Results:
- Transgenic mice developed severe cardiomyopathy with inflammation, fibrosis, and hypertrophy.
- Skeletal muscle genes were activated in the myocardium, leading to cardiac dysfunction.
- Lifespan was significantly reduced (average 109 days) due to heart failure.
Conclusions:
- Forcing skeletal muscle gene expression in the heart induces a fatal cardiomyopathy.
- Incompatibility between cardiac and skeletal muscle structural proteins likely causes pathology.
- This study provides insights into the molecular basis of heart disease.